Hawaii Finalizes $700 Million Agreement in Plavix Legal Case
Hawaii's legal challenge against certain pharmaceutical giants regarding the blood thinner Plavix has culminated in a significant settlement of $700 million, as declared by the state attorney general's department.
Originally, a judicial decision last year determined that Bristol Myers Squibb and several U.S. affiliates of the French company Sanofi were liable for $916 million.
However, before an appellate decision could be made, both parties agreed to a reduced settlement amount, according to statements from the attorney general's office.
The companies issued a collective statement expressing satisfaction with the resolution, stating their ongoing commitment to advancing medical innovation and delivering new treatments to patients.
They highlighted Plavix's nearly 30-year history of benefiting millions with cardiovascular conditions and noted its status as a preferred treatment globally according to leading health guidelines.
Labeling Concerns and Legal Outcome
Judge James Ashford previously raised concerns about the drug's effectiveness, noting that up to 30% of users, particularly those from non-Caucasian backgrounds, might not fully benefit, with no corresponding label updates from the companies, per statements made by Attorney General Anne Lopez last year.
Despite the settlement, neither company conceded any fault.
Governor Josh Green heralds the settlement as both a landmark decision and a monumental win for Hawaii.
Settlement Details
The attorney general's office has confirmed the even division of the $700 million sum between Bristol Myers Squibb and Sanofi. The payment will be executed via wire transfer by June 9.




Leave a Reply